Cardiovascular Medicine Book


Perioperative Beta Blocker

Aka: Perioperative Beta Blocker, Preoperative Beta Blocker
  1. See Also
    1. Preoperative Examination
    2. Preoperative Cardiovascular Evaluation
    3. Revised Cardiac Index
    4. Beta Blocker
    5. Metoprolol
  2. Indications
    1. See Preoperative Cardiovascular Evaluation
    2. Cardiac Risk Factors and not Low Risk Surgery
  3. Contraindications
    1. Criteria not met for AHA 2009 guidelines
      1. Revised Cardiac Index of 3 or more and
      2. Intermediate to High Risk Surgery
    2. Emergent surgery
    3. Beta Blocker allergy
    4. Bradycardia (resting Heart Rate <60)
    5. Second degree AV Heart Block (unless paced)
    6. Severe Obstructive Lung Disease
  4. Adverse Effects
    1. Perioperative Beta Blockers reduced cardiac events but were associated with more strokes and a higher mortality (POISE Trial)
      1. Increased adverse events appear to be associated with Hypotension due to recently started Beta Blocker
      2. For those on Beta Blockers at least 4 weeks, cardiovascular risk and mortality was decreased
    2. References
      1. Devereaux (2008) Lancet 371(9627): 1839-47 [PubMed]
      2. Rosenman (2008) Mayo Selected Topics in Internal Medicine, Lecture
  5. Protocol
    1. AHA guidelines (2009) modified indications for Perioperative Beta Blockers reflect adverse effects as above
    2. Continue Beta Blockers if already started (chronic use)
      1. Myocardial Infarction in the last 2-3 years
      2. Compensated Systolic Heart Failure
    3. Starting Perioperative Beta Blocker
      1. Contraindications
        1. See contraindications above
        2. Do not start a Preoperative Beta Blocker without careful consideration
          1. Avoid perioperatively starting Beta Blockers in lower risk patients (more adverse events)
        3. Lindenauer (2005) N Engl J Med 353(4): 349-61 [PubMed]
      2. Indications to start Beta Blocker
        1. Moderate to High Risk Surgery and Revised Cardiac Index of 3 or more or
        2. Vascular surgery with a positive stress test
      3. Initiate early (at least 2-4 weeks before surgery)
        1. Titrate to Heart Rate of 60-80 and avoid Hypotension
        2. Monitor preoperatively after starting
      4. Continue Beta Blocker for at least 30 days after surgery
    4. Indications to use half dose of Beta Blocker
      1. Small, elderly or frail patient
      2. Systolic Blood Pressure < 110 mmHg
      3. Heart Rate <65 beats per minute
    5. Indications to hold dose
      1. Heart Rate <50 beats per minute
    6. Indications to increase dose
      1. Heart Rate >80
    7. References
      1. Fleischmann (2009) J Am Coll Cardiol 54:2102-28 [PubMed]
  6. Preparations
    1. Modify dosing as per protocol above
    2. Metoprolol (succinate or XL is preferred)
      1. Metoprolol Succinate (Toprol XL)
        1. Standard dose: 100 mg orally daily until 14 days post-surgery
        2. Small, frail or elderly: 50 mg orally daily if indicated per protocol above
      2. Metoprolol Tartrate
        1. Standard dose: 50 mg orally twice daily until 14 days post-surgery
        2. Small, Frail or elderly: 25 mg orally twice daily
      3. Lopressor IV
        1. Standard dose: 10 mg IV q6 hours if unable to take oral
        2. Small, frail or elderly: Use 5 mg IV q6h if indicated per protocol above
        3. Convert to oral when able
        4. Continue for 14 days post-surgery
    3. Atenolol (older protocol, see protocol above)
      1. Initial dose: 5 mg IV 30 minutes before surgery
      2. Next dose: 5 mg IV immediately after surgery
      3. Maintenance: 50-100 mg PO qd for 7 days
    4. Bisoprolol (older protocol, see protocol above)
      1. Dose: 5-10 mg PO qd
      2. Start 7 days before surgery
      3. Continue for 30 days after surgery
    5. References
      1. Poldermans (1999) N Engl J Med 341:1789-94 [PubMed]
  7. Resources
    1. ACC/AHA 2014 Guideline on Perioperative Cardiovascular Evaluation and Management
    2. ACC/AHA 2014 Guideline on Perioperative Beta Blockade
  8. References
    1. Lindenauer (2005) N Engl J Med 353(4): 349-61 [PubMed]
    2. Thatcher (2005) Circulation 111: e310-59 [PubMed]

You are currently viewing the original '\legacy' version of this website. Internet Explorer 8.0 and older will automatically be redirected to this legacy version.

If you are using a modern web browser, you may instead navigate to the newer desktop version of fpnotebook. Another, mobile version is also available which should function on both newer and older web browsers.

Please Contact Me as you run across problems with any of these versions on the website.

Navigation Tree